ELTX
Elicio Therapeutics Inc.
1.90$
+0.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +4.8% | +1.4% | +1.0% | -1.0% | +5.2% | -8.9% | +1.1% | +0.7% | +1.1% | +1.0% | -2.1% | – | |
| – | -0.6% | -3.9% | +8.0% | -6.6% | +41.9% | +11.4% | +37.3% | -1.7% | +10.6% | +12.4% | +7.7% | – | |
| – | -134.2% | – | – | +38.3% | +109.1% | -109.6% | – | – | – | -241.1% | – | – | |
| – | -100.0% | – | – | +0.0% | +7.1% | -100.0% | – | – | – | -100.0% | – | – | |
| – | – | – | -1,500.0% | +0.0% | +7.1% | – | – | – | – | – | – | – | |
| – | -200.0% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | |
| – | +11,767.8% | +57.4% | -97.1% | +9,632.3% | -99.3% | +4,449.8% | +15.5% | -19.8% | -49.2% | +65.1% | +105.7% | – | |
| – | – | – | – | – | -136.3% | – | +1,173.3% | -148.3% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.